Evotec and Plectonic launch research collaboration for solid tumors immunotherapy
Evotec SE and Plectonic Biotech announced a research collaboration to explore a novel immunotherapy approach for solid tumors.
HAMBURG, Germany and HALLBERGMOOS, Germany, Sept.
2, 2026 // -- Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) and Plectonic Biotech today announced a research collaboration to explore a novel immunotherapy approach for solid tumors.
The collaboration addresses key challenges that…